CLVTClarivate Plc
The Read
Clarivate’s stock historically surged about 12% on strong Q1 2026 results driven by earnings and revenue beats, widened net margins, accelerated organic growth, and solid free cash flow fueling deleveraging and AI platform launches.
The schedule
- Wed14Oct
Clarivate's management is expected to address the looming 2027 debt maturities, a critical overhang given the company's $4.33B debt load and high leverage profile.
- Sun7Feb
The Q3 2026 earnings release will reveal the underlying strength of Clarivate's recurring subscription revenues in its Intellectual Property and Life Sciences divisions.
- Wed28Apr
The Q1 2027 earnings release will evaluate the early returns on Clarivate's 2027 strategic investments and the pace of its ongoing deleveraging efforts.
- Sun16May
Clarivate's Q4 2026 print and FY 2027 guidance will dictate the longer-term trajectory, focusing on AI-driven capex requirements versus top-line acceleration.
Past
- Wed5Aug
Actual outcome: Bear · $1.89 at outcome
Clarivate released its Q2 2026 earnings, beating consensus estimates and reaffirming its full-year financial outlook while announcing the appointment of a new CFO. Despite these solid results and a subsequent August 6 announcement detailing the expansion of Agentic AI across its Cortellis portfolio, the stock saw a muted reaction, falling just 2.6% by the outcome date. The market response was ultimately mixed, as the positive earnings and AI product momentum failed to drive a significant directional move.
Clarivate's Q2 2026 earnings print will serve as a crucial test for its Value Creation Plan, focusing on margin expansion and the monetization of AI-native research platforms.
- Mon15Jun
Actual outcome: Bear · $2.04 at outcome
Clarivate's strategic updates around its Annual General Meeting failed to deliver the concrete AI monetization metrics investors were seeking. Although the company announced minor developments, such as its IPfolio selection by Mitsubishi Fuso and the release of its 2026 Journal Citation Reports, the lack of substantial progress on its Value Creation Plan fueled execution fatigue and drove shares below the bear floor.
At the upcoming AGM, Clarivate is expected to update investors on its Value Creation Plan and recent AI-native research platform launches. Given the strong Q1 reception, management's commentary on accelerating organic revenue growth could drive the stock toward $2.65. However, if strategic updates lack concrete monetization metrics for the AI platforms, shares may drift down to $2.20 as execution fatigue sets in.
- Wed29Apr
Actual outcome: Bull · $2.78 at outcome
Clarivate delivered strong Q1 2026 results, beating consensus EPS and revenue estimates while significantly widening its net margins. The stock reached the bull target as investors reacted positively to accelerated organic revenue growth under the company's Value Creation Plan, solid free cash flow generation used for deleveraging, and the launch of new AI-native research platforms.
First quarter results under the 2026 strategic plan with focus on subscription retention.